Senate passes bill amending drug patent laws

Senate passes bill amending drug patent laws

The Senate passed the Greater Access to Affordable Pharmaceuticals Act (section 812) on July 31, 2002, approving amendments to patent laws to make generic drug options more available to US consumers. Currently manufacturers of brand name drugs are allowed to receive an automatic 30-month stay of gen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Intellectual property & technology law journal 2002-11, Vol.14 (11), p.20
Hauptverfasser: Tantono, Welly, Selby, Sharon, Bagner, Jessica, Sonu, Christine
Format: Artikel
Sprache:eng
Schlagworte:
Drugs
FDA approval
Federal legislation
Generic drugs
Intellectual property
Interpretation and construction
Litigation
Patent law
Pharmaceutical industry
Prescription drug plans
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Senate passed the Greater Access to Affordable Pharmaceuticals Act (section 812) on July 31, 2002, approving amendments to patent laws to make generic drug options more available to US consumers. Currently manufacturers of brand name drugs are allowed to receive an automatic 30-month stay of generic drug approval while litigation concerning infringement of the patent is pending. The Greater Access to Affordable Pharmaceuticals Act would limit such extensions, allowing drug manufacturers just one 30-month stay.
ISSN:1534-3618